办事指南

Newswire : Gene business

点击量:   时间:2017-10-23 06:02:05

Icelanders, whose unusually low genetic variability makes them ideal for studies on the origin of diseases, have agreed to reveal the secrets of their genes to pharmaceuticals company Hoffmann-La Roche. The deal, worth $200 million, gives the company and its partner—deCode Genetics of Reykjavik—exclusive rights to develop drugs from the genetic data of Iceland’s population. In return,